| 0.8794 -0.691 (-43.99%) | 06-25 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.84 |
1-year : | 2.45 |
| Resists | First : | 1.57 |
Second : | 2.09 |
| Pivot price | 1.67 |
|||
| Supports | First : | 0.73 |
Second : | 0.61 |
| MAs | MA(5) : | 1.44 |
MA(20) : | 1.73 |
| MA(100) : | 2.13 |
MA(250) : | 3.19 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 7.9  |
D(3) : | 6.7 |
| RSI | RSI(14): 22.6 |
|||
| 52-week | High : | 5.69 | Low : | 0.73 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NNOX ] has closed below the lower bollinger band by 28.8%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ NNOX ] is to continue within current trading range. It is unclear right now based on current values. 59.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.18 - 1.19 | 1.19 - 1.2 |
| Low: | 0.72 - 0.73 | 0.73 - 0.73 |
| Close: | 0.87 - 0.88 | 0.88 - 0.89 |
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Thu, 25 Jun 2026
Nano-X Imaging Earnings Call: Growth Amid Cash Strain - TipRanks
Thu, 25 Jun 2026
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages - GlobeNewswire
Thu, 25 Jun 2026
Nano X Imaging Ltd (NNOX) Q1 2026 Earnings Call Highlights: Reve - GuruFocus
Thu, 25 Jun 2026
Deadline Alert: Nano-X Imaging Ltd. (NNOX) Shareholders Who Lost - The National Law Review
Thu, 25 Jun 2026
Nano-X stock falls on Q1 miss, going concern risk (NNOX:NASDAQ) - Seeking Alpha
Thu, 25 Jun 2026
Nano X Imaging Q1 2026 Earnings Call Transcript - Benzinga
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 70 (M) |
| Shares Float | 69 (M) |
| Held by Insiders | 0.3 (%) |
| Held by Institutions | 27 (%) |
| Shares Short | 10,130 (K) |
| Shares Short P.Month | 13,200 (K) |
| EPS | -1.16 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2 |
| Profit Margin | 0 % |
| Operating Margin | -479.4 % |
| Return on Assets (ttm) | -20.4 % |
| Return on Equity (ttm) | -45.7 % |
| Qtrly Rev. Growth | 24 % |
| Gross Profit (p.s.) | -0.19 |
| Sales Per Share | 0.18 |
| EBITDA (p.s.) | -0.71 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -41 (M) |
| Levered Free Cash Flow | -25 (M) |
| PE Ratio | -0.76 |
| PEG Ratio | 0 |
| Price to Book value | 0.43 |
| Price to Sales | 4.7 |
| Price to Cash Flow | -1.51 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|